Jennifer Burstein, Senior VP of Finance at Loxo Oncology, Inc. (LOXO), sold 1,700 shares at $131.75 ($223K) on 2018-03-13, disclosed to the SEC on 2018-03-15.
Open-market sale of $223k LOXO by Senior VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.85 | 100 | $13K | 5.8% |
| 2 | $130.23 | 700 | $91K | 40.8% |
| 3 | $131.75 | 500 | $66K | 29.5% |
| 4 | $133.04 | 300 | $40K | 17.9% |
| 5 | $134.28 | 100 | $13K | 6.0% |
| Total | $131.33 avg | 1,700 |
| $223K |
| 100% |
| Filing → |
| LOXO | SELL | 2018-10-05 | $742K | — | Filing → |
| LOXO | SELL | 2018-09-14 | $667K | — | Filing → |
| LOXO | SELL | 2018-08-15 | $540K | — | Filing → |